Cysteinyl leukotrienes and collagen type I synthesis in asthma [4]

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 1, 2004, Pages 197-199

  Nomura, Akihiro ^a   Kodama, Takahide ^a   Morishima, Yuko ^a   Ishii, Yukio ^a   Sakamoto, Tohru ^a   Kimura, Toru ^a   Sekizawa, Kiyohisa ^a  

^a Dept Pulmon Med Inst Clin M ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FLUTICASONE PROPIONATE; MONTELUKAST; PEPTIDOLEUKOTRIENE; PROCOLLAGEN C PROTEINASE; SALBUTAMOL;

ADULT; ASTHMA; CLINICAL ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LABORATORY TEST; LETTER; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPUTUM ANALYSIS; TREATMENT OUTCOME;

ACETATES; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; COLLAGEN TYPE I; EOSINOPHILS; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PEPTIDE FRAGMENTS; PILOT PROJECTS; PROCOLLAGEN; QUINOLINES; RECEPTORS, LEUKOTRIENE; SPUTUM;

EID: 3442887059     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.03.037     Document Type: Letter

References (10)

1. Dahlen S.E., Hedqvist P., Hammarstrom S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 288:1980;. 48-6
2. Finnerty J.P., Wood-Baker R., Thomson H., Holgate S.T. Role of leukotrienes in exercise-induced asthma: inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am Rev Respir Dis. 145:1992;746-749
3. Horwitz R.J., McGill K.A., Busse W.W. The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med. 157:1998;1363-1371
4. Virchow J.C. Jr., Faehndrich S., Nassenstein C., Bock S., Matthys H., Luttmann W. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. Clin Exp Allergy. 31:2001;836-844
5. Panettieri R.A., Tan E.M., Ciocca V., Luttmann M.A., Leonard T.B., Hay D.W. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol. 19:1998;453-461
6. Abe M., Kurosawa M., Ishikawa O., Miyachi Y. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol. 106:2000;S78-S84
7. Phan S.H., McGarry B.M., Loeffler K.M., Kunkel S.L. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry. 27:1988;2846-2853
8. Henderson W.R. Jr., Tang L.O., Chu S.J., Tsao S.M., Chiang G.K., Jones F., et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med. 165:2002;108-116
9. Nomura A., Uchida Y., Sakamoto T., Ishii Y., Masuyama K., Morishima Y., et al. Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor-beta. Clin Exp Allergy. 32:2002;860-865
10. Pizzichini E., Leff J.A., Reiss T.F., Hendeles L., Boulet L.P., Wei L.X., et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized controlled trial. Eur Respir J. 14:1999;12-18